About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
potassium inwardly rectifying channel, subfamily J, member 11
68 phenotypes from 6 alleles in 11 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
involves: C57BL/6 * CBA/J
abnormal circulating glucagon level J:146650
abnormal circulating glucose level J:146650
abnormal pancreas morphology J:146650
abnormal pancreatic alpha cell morphology J:146650
abnormal pancreatic beta cell physiology J:146650
abnormal pancreatic islet morphology J:146650
decreased circulating glucagon level J:146650
decreased circulating insulin level J:146650
decreased insulin secretion J:146650
decreased pancreas weight J:146650
decreased pancreatic alpha cell number J:146650
decreased pancreatic beta cell number J:146650
decreased pancreatic islet number J:146650
hyperglycemia J:146650
increased circulating glucagon level J:146650
slow postnatal weight gain J:146650
small pancreatic islets J:146650
involves: 129S4/SvJae * C57BL/6 * SJL
abnormal action potential J:162008
abnormal channel response J:162008
abnormal nervous system electrophysiology J:162008
decreased body weight J:162008
decreased grip strength J:162008
hyperactivity J:162008
impaired balance J:162008
impaired coordination J:162008
muscle weakness J:162008
perinatal lethality, incomplete penetrance J:162008
involves: 129S4/SvJae * C57BL/6
abnormal pancreatic alpha cell morphology J:144715
abnormal pancreatic beta cell morphology J:144715
abnormal pancreatic beta cell physiology J:144715
abnormal pancreatic islet morphology J:144715
decreased body weight J:144715
decreased circulating insulin level J:144715
decreased insulin secretion J:144715
decreased pancreatic beta cell number J:144715
increased circulating glucagon level J:144715
increased circulating glucose level J:144715
increased pancreatic alpha cell number J:144715
polyuria J:144715
involves: 129S4/SvJae * C57BL/6 * CBA
hyperglycemia J:210493
decreased fasted circulating glucose level J:211773
impaired glucose tolerance J:211773
involves: 129P2/OlaHsd * C57BL/6 * CBA
abnormal pancreatic beta cell physiology J:94610
decreased insulin secretion J:94610
impaired glucose tolerance J:94610
improved glucose tolerance J:94610
increased circulating glucose level J:94610
increased circulating insulin level J:94610
increased insulin secretion J:94610
abnormal action potential J:106396
abnormal food intake J:69163, J:157001
abnormal glucose homeostasis J:69163
abnormal locomotor activation J:157001
abnormal nerve fiber response J:69163
decreased abdominal fat pad weight J:157001
decreased aerobic running capacity J:157001
decreased glucagon secretion J:69163
decreased subcutaneous adipose tissue amount J:157001
decreased susceptibility to diet-induced obesity J:157001
hypoglycemia J:69163
increased circulating atrial natriuretic factor J:106396
increased energy expenditure J:157001
increased mean systemic arterial blood pressure J:106396
increased oxygen consumption J:157001
normal pigmentation phenotype J:157001
slow postnatal weight gain J:157001
involves: 129P2/OlaHsd
abnormal muscle relaxation J:105244
abnormal nerve fiber response J:69832
abnormal nerve fiber response intensity J:69832
convulsive seizures J:69832
decreased circulating insulin level J:49755
impaired glucose tolerance J:49755
impaired skeletal muscle contractility J:105244, J:140833
increased insulin sensitivity J:49755
increased sensitivity to induced morbidity/mortality J:69832
muscle fatigue J:140833
myoclonus J:69832
tonic-clonic seizures J:69832
involves: 129P2/OlaHsd * C57BL/6
abnormal emotion/affect behavior J:112822
abnormal locomotor activation J:112822
abnormal motor capabilities/coordination/movement J:112822
abnormal spatial reference memory J:112822
decreased anxiety-related response J:112822
decreased exploration in new environment J:112822
decreased vertical activity J:112822
impaired coordination J:112822
increased anxiety-related response J:112822
involves: 129P2/OlaHsd * C57BL/6 * CBA
decreased insulin secretion J:94610
normal homeostasis/metabolism phenotype J:94610
impaired glucose tolerance J:94610
increased circulating glucose level J:94610
involves: BALB/c * C3H/HeH
decreased glucagon secretion J:122088
increased insulin secretion J:122088
increased insulin secretion J:94610

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
MGI 6.13
The Jackson Laboratory